43. Biron CA, Young HA, Kasaian MT. 1990. Interleukin 2-induced proliferation of murine natural killer cells in vivo. J. Exp. Med. 171:173. 44. Robertson, M.J. and J. Ritz (1992). Chapter 12 in NK Mediated Cytotoxicity: Receptors, Signaling and Mechanisms, E. Lotsova, ed., CRC Press, Boca Raton, Fla., p. 184. 45. Shibuya A, Kojima H, Shibuya K et al. 1993. Enrichment of interleukin-2-responsive natural killer progenitors in human bone marrow. Blood 81:1819. 46. Spagnoli G. C., Juretic A., Schultz-Thater E., Dellabona P., Filgueira L., Horig H., Zuber M., Garotta G., Heberer M. 1993. On the relative roles of interleukin-2 and interleukin-10 in the generation of lymphokine-activated killer cell activity.Cell. Immunol. 146:391. 47. Lotze, M. T., E. A. Grimm, A. Mazumder, J. L. Strausser, and S. A. Rosenberg. 1981. Lysis of fresh and cultured autologous tumor by human lymphocytes cultured in T-cell growth factor. Cancer Res. 41: 4420. 48. Grimm EA, Mazumder A, Zhang HZ, Rosenberg SA. 1982. Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes. J. Exp. Med. 155:1823. 49. : Djeu JY, Liu JH, Wei S, Rui H, Pearson CA, Leonard WJ, Blanchard DK. 1993. Function associated with IL-2 receptor-beta on human neutrophils. Mechanism of activation of antifungal activity against Candida albicans by IL-2. J. Immunol. 150:960. 50. . Kjeldsen-Kragh, J., A. J. Quayle, B. S. Skalhegg, M. Sioud, O. Forre.